ET‐1 is an endogenous peptide with strong vasoactive properties involved in various lung disorders such as pulmonary hypertension, acute respiratory failure and development of bronchopulmonary dysplasia (Fagan et al. Here, EDN1 is linked to pulmonary hypertension.